ROSE; Lars

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROSE; Lars.The latest application filed is for "combinations of anti-ildr2 antibodies and pd-1 antagonists".

Company Profile

3.2.13

ROSE; Lars - Berlin DE
Rose; Lars - Vancouver CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations Of Anti-ildr2 Antibodies And Pd-1 Antagonists App 20220169736 - ROSE; Lars ; et al.	2022-06-02
Combination Of Regorafenib And Pd-1/pd-l1(2) Inhibitors For Treating Cancer App 20220133888 - HOFF; Sabine ; et al.	2022-05-05
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists Grant 11,304,946 - Lefranc , et al. April 19, 2	2022-04-19
3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides Grant 11,040,035 - Schmees , et al. June 22, 2	2021-06-22
Ildr2 Antagonists And Combinations Thereof App 20200369769 - ROSE; Lars ; et al.	2020-11-26
Sulphur Substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides App 20200299269 - ZORN; Ludwig ; et al.	2020-09-24
2-hetarylpyrimidine-4-carboxamides As Aryl Hydrocarbon Receptor Anatgonists App 20200289509 - LEFRANC; Julien ; et al.	2020-09-17
3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides App 20200283402 - GUTCHER; Ilona ; et al.	2020-09-10
2-phenylpyrimidine-4-carboxamides As Ahr Inhibitors App 20200283395 - LEFRANC; Julien ; et al.	2020-09-10
Combination Of Regorafenib And Pd-1/pd-l1(2) Inhibitors For Treating Cancer App 20200188372 - HOFF; Sabine ; et al.	2020-06-18
Combination Of Regorafenib And Pd-1/pd-l1(2) Inhibitors For Treating Cancer App 20200179354 - HOFF; Sabine ; et al.	2020-06-11
Combination Of Regorafenib And Pd-1/pd-l1(2) Inhibitors For Treating Cancer App 20200155674 - HOFF; Sabine ; et al.	2020-05-21
Application Of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one Systems In The Treatment Of Menorrhagia, As Well As Intrauterine Systems Containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one For Treating Uterine Bleeding Disorders App 20150119372 - Schmees; Norbert ; et al.	2015-04-30
Intrauterine Application Of 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one Systems, Intrauterine Systems Containing 18-methyl-15ss,16ss-methylene-19-nor-20-spirox-4-en-3-one, As Well As The Use Thereof In Contraception And Gynaecological Therapy App 20150065472 - Schmees; Norbert ; et al.	2015-03-05
Densified Ceramic Materials And Related Methods App 20100092842 - Rose; Lars ; et al.	2010-04-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.